Skip to content

The Coronavirus Impact Scale Validity and Reliability Study

Turkish Validity and Reliability Study of The Coronavirus Impact Scale

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05017506
Enrollment
500
Registered
2021-08-24
Start date
2021-09-01
Completion date
2022-03-21
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TURKISH VALIDITY AND RELIABILITY STUDY OF THE CORONAVIRUS IMPACT SCALE

Keywords

Coronovirus, Impact, Reliability, Validity, Measuring tool, Nursing.

Brief summary

This research; The Turkish validity and reliability study of the Coronavirus Impact Scale developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country.

Detailed description

This research; The Turkish validity and reliability study of the Coronavirus Impact Scale developed by Stoddard and Kaufman (2020) will be conducted in order to bring a new measurement tool to our country. Method: This research was planned as a methodological study. Research Question: Is the Coronavirus Impact Scale a valid and reliable measurement tool for Turkish society?

Interventions

OTHERA survey will be made.

A survey will be made.

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years old, * At least primary school graduate, * Able to communicate verbally and * Persons who agree to participate in the research will be included in the research.

Exclusion criteria

* Psychiatric illness and unable to communicate, * Having a language problem * Persons who do not have the skills to read and understand the questionnaire will be excluded from the research.

Design outcomes

Primary

MeasureTime frameDescription
Coronavirus Impact Scale8 monthsThe Coronovirus Impact Scale was developed by Stoddard and Kaufman (2020) to assess the impact of Covid-19 on people. The scale consists of 12 questions. Questions 1-9 in the scale are in 4-point Likert type, 0. There is no change, 1. Mild, 2. Moderate and 3. Severe, and points are taken between 0-3 from these questions. The questions between 10 and 11 on the scale are in a 5-point Likert type and are scored between 0-4 (indicating that from mild symptoms to death). However, the number of first degree family members diagnosed with coronavirus in question 10 and the number of relatives or close friends diagnosed with coronavirus in question 11 are not taken into account in the scale. The 12th question of the scale is open-ended and determines the other aspects that the coronavirus epidemic affects life. A minimum score of 0 and a maximum score of 35 are obtained from the scale, and as the score increases, the degree of exposure of people to the Corona virus increases.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026